Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy.

Phillips DR, Hay P.

J Antimicrob Chemother. 2008 Nov;62(5):866-71. doi: 10.1093/jac/dkn318. Epub 2008 Aug 13. Review.

PMID:
18703527
2.

Therapeutic approaches to combating lipoatrophy: do they work?

Martin A, Mallon PW.

J Antimicrob Chemother. 2005 May;55(5):612-5. Epub 2005 Mar 10. Review.

PMID:
15761072
3.

Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

Nolan D, Mallal S.

Sex Health. 2005;2(3):153-63. Review.

PMID:
16335543
4.
5.

[Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].

Streinu-Cercel A, Ion DA, Chivu LI, Chivu RD.

Rev Med Chir Soc Med Nat Iasi. 2006 Jul-Sep;110(3):521-5. Review. Romanian.

PMID:
17571539
6.

HIV-associated facial lipoatrophy.

James J, Carruthers A, Carruthers J.

Dermatol Surg. 2002 Nov;28(11):979-86. Review.

PMID:
12460289
7.

HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options.

Mallewa JE, Wilkins E, Vilar J, Mallewa M, Doran D, Back D, Pirmohamed M.

J Antimicrob Chemother. 2008 Oct;62(4):648-60. doi: 10.1093/jac/dkn251. Epub 2008 Jun 18. Review.

PMID:
18565973
8.

Interventions for managing antiretroviral therapy-associated lipoatrophy.

Sutinen J.

Curr Opin Infect Dis. 2005 Feb;18(1):25-33. Review.

PMID:
15647696
9.

Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.

Barbaro G.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):337-43.

PMID:
16101566
10.

The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.

Nolan D, Mallal S.

J HIV Ther. 2004 May;9(2):34-40. Review.

PMID:
15238874
11.

What does the term "HIV-associated lipodystrophy" mean?

Marcason W.

J Am Diet Assoc. 2009 Feb;109(2):364. doi: 10.1016/j.jada.2008.12.005. No abstract available.

PMID:
19167963
12.
13.

HIV and increased risk of cardiovascular diseases.

Das S.

Sex Health. 2005;2(4):219-21. Review.

PMID:
16402668
15.

Treatment of facial lipoatrophy via autologous fat transfer.

Cohen G, Treherne A.

J Drugs Dermatol. 2009 May;8(5):486-9.

PMID:
19537373
16.

[Metabolic abnormalities, lipodystrophy and cardiovascular risk in HIV-infected patients].

Leclercq P, Blanc M.

Rev Prat. 2006 May 15;56(9):987-94. Review. French.

PMID:
16775979
17.

Strategies in the treatment of HIV-1-associated adipose redistribution syndromes.

del Mar Gutierrez M, Mateo G, Domingo P.

Expert Opin Pharmacother. 2007 Aug;8(12):1871-84. Review.

PMID:
17696790
18.

HIV-associated lipodystrophy syndrome.

Milinković A.

Coll Antropol. 2006 Dec;30 Suppl 2:59-62.

PMID:
17508476
19.
20.

[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].

Calza L, Manfredi R, Chiodo F.

Recenti Prog Med. 2004 May;95(5):265-75. Review. Italian.

PMID:
15202680

Supplemental Content

Support Center